Sei Investments Co. Acquires 75,193 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Sei Investments Co. lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 13.2% during the second quarter, HoldingsChannel.com reports. The firm owned 645,244 shares of the company’s stock after purchasing an additional 75,193 shares during the quarter. Sei Investments Co.’s holdings in HealthEquity were worth $55,620,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Rise Advisors LLC purchased a new position in HealthEquity during the first quarter valued at $28,000. Cape Investment Advisory Inc. bought a new position in shares of HealthEquity during the fourth quarter valued at $27,000. International Assets Investment Management LLC purchased a new position in shares of HealthEquity in the 2nd quarter worth about $35,000. YHB Investment Advisors Inc. bought a new position in HealthEquity in the 1st quarter worth about $40,000. Finally, Fidelis Capital Partners LLC purchased a new stake in HealthEquity during the 1st quarter valued at about $42,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

NASDAQ HQY opened at $79.53 on Monday. The company has a 50-day moving average price of $76.17 and a 200-day moving average price of $79.31. HealthEquity, Inc. has a 52 week low of $61.81 and a 52 week high of $88.26. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $6.92 billion, a P/E ratio of 86.45, a PEG ratio of 1.19 and a beta of 0.52.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on HQY shares. JMP Securities reiterated a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Wells Fargo & Company lifted their target price on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a report on Thursday, June 20th. Raymond James upped their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Friday, June 7th. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Barrington Research restated an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Friday. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $103.83.

Insider Activity at HealthEquity

In other news, Director Frank Corvino sold 7,705 shares of HealthEquity stock in a transaction on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the transaction, the director now owns 6,070 shares in the company, valued at approximately $497,072.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HealthEquity news, Director Frank Corvino sold 7,705 shares of the company’s stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the sale, the director now owns 6,070 shares in the company, valued at $497,072.30. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the transaction, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.